Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Novo Nordisk posts hefty Q3 gains

Country: Denmark

Novo Nordisk A/S posted hefty gains in sales and operating profit for the third quarter and first nine months of 2014 driven by demand for the long-acting insulin product Levemir and the glucagon-like peptide-1 agonist (GLP-1) Victoza.

Read more

Cambridge Epigenetix gets Series A funding

Country: United Kingdom

Cambridge Epigenetix Ltd (CEGX), a spinout of the University of Cambridge that makes epigenetics tools, has raised $5.5 million from venture capital organisations in a Series A round. The financing was led by New Science Ventures LLP of New York, New York.

Read more

Sanofi ousts Viehbacher

Country: France

Read more

BMS takes option on F-star Alpha

Country: United Kingdom

Read more

Novartis reports improved profit margins

Country: Switzerland

Read more

ImevaX gets funding for vaccine project

Country: Germany

Read more

Advent Life Sciences raises £145.5 million

Country: United Kingdom

Read more

Olaparib recommended for ovarian cancer

Country: United Kingdom

Read more

Novartis sells its flu business to CSL

Country: Switzerland

Read more

Shire raises guidance after banner third quarter

Country: Ireland

Read more

Erytech raises €30 million in capital increase

Country: France

Read more

Probiodrug raises €22.5 million in IPO

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Commentary- A greater patient voice in drug development by Richard Pops

CommentaryRichardPopsOct2014.pdf

Highlights of the October 2014 MedNous issue

The October 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    Why European biopharma
    is starved for capital
  • Oncology Review
    New agents fight
    B-cell malignancies
  • Commentary
    Collaboration to deliver
    superior value to patients
    by Roch Doliveux
  • Commentary
    A greater patient voice in drug development
    By Richard Pops
  • Regulatory
    EMA to make clinical data public
  • Regulatory
    Nobel Prize awarded for brain research

The latest MedNous journal. Subscribe to download.

Recent Appointments